JinhaI Med Tech (02225): Ma Chengdong has been appointed as Chief Marketing Officer.

18:13 03/08/2026

Today, Hai Medical Technology (02225) announced that Mr. Ma Chengdong has been appointed as the Group Chief Marketing Officer, effective from August 3, 2026, with an initial term of one year. He will be primarily responsible for the Group's marketing strategy for products, market access, academic promotion, as well as sales and channel operations, and will oversee the commercialization of the Group's medical devices and equipment products.

JINHAI MED TECH (02225) announced that Mr. Ma Chengdong has been appointed as the Chief Marketing Officer of the group, effective from August 3, 2026, with an initial term of one year. He will be primarily responsible for the group's marketing strategy for products, market access, academic promotion, and sales and channel operations, as well as overseeing the commercialization of the group's medical devices and equipment products.

Guangzhou Automobile Group (601238.SH) plans to issue no more than 15 billion yuan in debt financing instruments.

Morgan Stanley increases its holdings in DELTON (01989) by approximately 161,900 shares, priced at HK$91.94 per share.

CN INT DEV CORP (00264) has entered into a procurement contract for prefabricated artificial intelligence data center modules.

Guangzhou Automobile Group (601238.SH) plans to issue no more than 15 billion yuan in debt financing instruments.

Morgan Stanley increases its holdings in DELTON (01989) by approximately 161,900 shares, priced at HK$91.94 per share.

CN INT DEV CORP (00264) has entered into a procurement contract for prefabricated artificial intelligence data center modules.